Compare Immunovant Inc. Common Stock (IMVT) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Alliant Energy Corporation — how do they compare? Immunovant Inc. Common Stock trades at $30.36 (market cap $6.25B), while Alliant Energy Corporation trades at $65.84 (market cap $16.99B). The key difference: Alliant Energy Corporation is far larger — about 2.7× Immunovant Inc. Common Stock's market cap, and Alliant Energy Corporation pays a 3.27% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and Alliant Energy Corporation for 64 Days on average.
| IMVT | LNT | |
|---|---|---|
Market Cap | $6.25B | $16.99B |
Volume | 1,755,411 | 2,488,387 |
Sector | Health | Utilities |
52-Week High | $44.96 | $78.03 |
52-Week Low | $17.03 | $63.21 |
Typical Hold Time | 1 Days | 64 Days |
Enterprise Value | $5.35B | $29.08B |
Dividend Yield | — | 3.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LNT trades at $65.84, up 0.97% today, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported strong earnings beats in recent quarters and maintains solid profitability with an 18.45% net margin. Analyst consensus is bullish with a $77 price target, and institutional interest remains high, evidenced by recent large purchases.
LNT's outlook is supported by a $13.4 billion capital investment plan and growing data center demand, though rising debt levels and competitive pressures present risks. The stock offers a defensive income stream with a consistent dividend, but investors should monitor execution of growth initiatives amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
